Sustained activation of non-canonical NF-κB signalling drives glycolytic reprogramming in doxorubicin-resistant DLBCL

Sustained activation of non-canonical NF-κB signalling drives glycolytic reprogramming in doxorubicin-resistant DLBCL

DLBCL is the most common lymphoma with high tumor heterogeneity. Treatment refractoriness and relapse from R-CHOP therapy in patients remain a clinical problem. Activation of the non-canonical NF-κB pathway is associated with R-CHOP resistance. However, downstream targets of non-canonical NF-κB medi...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak: Lim, Shen Kiat, Peng, Chen Chen, Low, Shannon, Vijay, Varsheni, Budiman, Andrea, Phang, Beng Hooi, Lim, Jing Quan, Jeyasekharan, Anand D., Lim, Soon Thye, Ong, Choon Kiat, Tan, Suet Mien, Li, Yinghui
Beste egile batzuk: School of Biological Sciences
Formatua: Journal Article
Hizkuntza:English
Argitaratua: 2023
Gaiak:
Science::Biological sciences
Cell Signalling
Non-Hodgkin Lymphoma
Sarrera elektronikoa:https://hdl.handle.net/10356/164468

Internet

https://hdl.handle.net/10356/164468

Antzeko izenburuak